D.E. Shaw & Co
RAIN

D.E. Shaw & Co’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

D.E. Shaw & Co’s Portfolio RAIN Stock Details RAIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15,923
Closed -$238K – 5807
2021
Q3 		$238K Sell
15,923
-11,799
-43% -$201K ﹤0.01% 4489
2021
Q2 		$431K Buy
+27,722
New +$486K ﹤0.01% 4106

Other funds holding RAIN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

D.E. Shaw & Co's RAIN Position: Q4 2021 in Review

D.E. Shaw & Co sold out of Rain Oncology Inc. Common Stock (RAIN) in Q4 2021, closing a stake of 15,923 shares — an estimated $238K sold.

D.E. Shaw & Co first reported a position in RAIN in Q2 2021 and held it in 2 quarters. The position peaked at $431K in Q2 2021. 41 funds tracked by Wall St. Rank hold RAIN as of Q4 2021.

  • D.E. Shaw & Co reported no remaining Rain Oncology Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • D.E. Shaw & Co sold 15,923 Rain Oncology Inc. Common Stock shares in Q4 2021, an estimated $238K.
  • D.E. Shaw & Co first reported a position in Rain Oncology Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • D.E. Shaw & Co's Rain Oncology Inc. Common Stock position peaked at $431K in Q2 2021.
  • 41 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q4 2021.

Based on D.E. Shaw & Co's 13F filing for Q4 2021, filed 14 Feb 2022.